Series A funding round for LimmaTech Biologics raising $36M in October 2023
Series A funding round for LimmaTech Biologics raising $36M in October 2023
| Investor | Firm Type | Partner |
|---|
Novo VenturesLEAD | Venture Capital | — |
Adjuvant CapitalLEAD | Venture Capital | — |
AXA IM AltsLEAD | Venture Capital | — |
This company has completed 2 funding rounds. Current round is highlighted.
Total Raised
$39M
Top Valuation
-
LimmaTech Biologics raised $36M in a Series A round.
The round was announced on 10/01/23.
The round was led by Adjuvant Capital, Zina Affas Besse, Camilla Petrycer Hansen.